Tyrosine Kinase-Inhibitors effective in epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCL)

被引：0
|
作者：
Pommer, Peter
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2016年 / 141卷 / 18期
关键词：
D O I：
10.1055/s-0042-110629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1284 / 1284
页数：1
相关论文
共 50 条
  • [31] Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) impact on immune microenvironment in non-small cell lung cancer (NSCLC).
    Tang, Jie
    Liu, XiaoLing
    Gong, Youling
    Zhu, Jiang
    Huang, Meijuan
    Ding, Zhenyu
    Yu, Min
    Tie, Yan
    Li, Qiu
    Wang, Yongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors on Brain Metastases in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Zhou, Qing
    Zhang, Xuchao
    Xu, Chongrui
    Yang, Jinji
    Yang, Xuening
    An, Shejuan
    Chen, Zhihong
    Su, Jian
    Wang, Binchao
    Huang, Yisheng
    Wang, Zhen
    Huang, Yujuan
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S398 - S398
  • [33] Epidermal growth factor receptor (EGFR) gene amplification in non-small cell lung cancer (NSCLC): molecular patterns and sensitivity to tyrosine kinase inhibitors
    Skokan, Margaret C.
    Gajapathy, Sujatha
    Xiao, Yun
    Franklin, Wilbur A.
    Hirsch, Fred R.
    Bunn, Paul A., Jr.
    Varella-Garcia, Marileila
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S322 - S322
  • [34] Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Nishinarita, Noriko
    Igawa, Satoshi
    Kasajima, Masashi
    Kusuhara, Seiichiro
    Harada, Shinya
    Okuma, Yuriko
    Sugita, Keisuke
    Ozawa, Takahiro
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Yokoba, Masanori
    Katagiri, Masato
    Kubota, Masaru
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    ONCOLOGY, 2018, 95 (02) : 109 - 115
  • [35] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Kaiyan Chen
    Xiaoqing Yu
    Haiyang Wang
    Zhiyu Huang
    Yanjun Xu
    Lei Gong
    Yun Fan
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 1179 - 1187
  • [36] Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer
    Yang, SH
    Mechanic, LE
    Yang, P
    Landi, MT
    Bowman, ED
    Wampfler, J
    Meerzaman, D
    Hong, KM
    Mann, F
    Dracheva, T
    Fukuoka, J
    Travis, W
    Caporaso, NE
    Harris, CC
    Jen, A
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2106 - 2110
  • [37] Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
    Karachaliou, Niki
    Rosell, Rafael
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 114 - 117
  • [38] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [39] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
    Jamal-Hanjani, Mariam
    Spicer, James
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 938 - 944
  • [40] STUDY OF THE SAFETY AND EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN 97 PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER
    Ishibashi, M.
    Ogawa, K.
    Motizuki, S.
    Hanada, S.
    Uruga, H.
    Takaya, H.
    Miyamoto, A.
    Morokawa, N.
    Fujii, T.
    Kishi, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 433 - 433
12345